Health care stocks were steady pre-bell Friday as the iShares Biotechnology ETF (IBB) and Health Care Select Sector SPDR Fund (XLV) were inactive recently.
CVS Health (CVS) shares fell by over 7% after the company said it expects Q3 adjusted earnings per share of $1.05 to $1.10, including charges to record premium deficiency reserves of around $1.1 billion that lowered its Q3 adjusted EPS by $0.63.
Orgenesis (ORGS) shares tumbled by over 33% after the company said in a regulatory filing that Nasdaq decided to delist the company's shares as it was not in compliance with listing requirements and trading will be suspended on Monday.
Bright Minds Biosciences (DRUG) shares surged past 64% after the company launched a private placement of common shares at a price of $21.70 per share.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。